Biotech Healthcare

Biotech Healthcare We believe in Innovation and Technology to bring the best Medical Solutions to you.

Biotech Group is specialized in the design; manufacture and marketing of medical implant devices for ophthalmology, and is focused on hyaluronic acid based medical implants for various specialties. By combining research and technology, Biotech Group innovates for ophthalmic surgery, for osteoarthritis treatment, and for skin rejuvenation by launching high quality health products in global markets.

10/04/2026

Presbyopia Awareness Month
How can we correct Presbyopia?

There are many options to correct Presbyopia: prescription eyeglasses, specialized contact lenses, or refractive surgery which offers several options, including Intraocular Lenses.

06/04/2026

Presbyopia Awareness Month
What is Presbyopia?

Presbyopia, commonly known as age-related farsightedness, is a natural part of ageing, not a disease.

Presbyopia happens when your eyes gradually lose the ability to see things clearly up close. It is a normal part of ageing. In fact, the term “presbyopia” comes from a Greek word which means “old eye”. You may start to notice presbyopia shortly after age 40. You will probably find that you hold reading materials farther away in order to see them clearly.

04/04/2026

OPTIFLEX XTENSE. Full Visual Range EDOF IOL
See the World – Bogotá (Colombia)

Travelling the world, seeing its monuments, from all distances with smooth continuous vision, in all light conditions and no disturbing glares nor halos* even in dim light, without the need of reading glasses, A vision to enjoy all the colors of the world, with clarity and improved contrast.

OPTIFLEX XTENSE Comfort Plus represents a major revolution in cataract outcomes and presbyopia correction. A hydrophobic EDOF intraocular lens with purely refractive optic, OPTIFLEX XTENSE delivers a continuous full visual range, from distance to intermediate to true near vision. Expanded visual range, minimal compromise and maximum clarity.

𝐀𝐩𝐫𝐢𝐥 𝐢𝐬 𝐏𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 It highlights the natural, age-related loss of near focusing ability affecting billi...
01/04/2026

𝐀𝐩𝐫𝐢𝐥 𝐢𝐬 𝐏𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡

It highlights the natural, age-related loss of near focusing ability affecting billions globally, typically starting after age 40. It promotes understanding of the symptoms and encourages exploring solutions.

𝐊𝐞𝐲 𝐀𝐬𝐩𝐞𝐜𝐭𝐬 𝐨𝐟 𝐏𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚:

- 𝐓𝐡𝐞 𝐂𝐚𝐮𝐬𝐞: It is a natural part of ageing, not a disease. The crystalline lens in our eye becomes stiffer, muscles around the lens weaken, causing near vision to become blurry.
- 𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬: The most common sign is needing to hold reading materials or digital screens farther away to see them clearly.
- 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: Numerous options exist to correct it, including prescription eyeglasses, specialized contact lenses, or surgical options.

Biotech is one of the leading companies 𝐩𝐫𝐨𝐯𝐢𝐝𝐢𝐧𝐠 𝐚 𝐰𝐢𝐝𝐞 𝐫𝐚𝐧𝐠𝐞 𝐨𝐟 𝐈𝐎𝐋𝐬 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐜𝐨𝐫𝐫𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐩𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚 which also aims to reduce the stigma associated with age-related vision changes and empower people to maintain their quality of life.

During this month, we will go through all aspects of Presbyopia.
Stay Tuned!

25/03/2026

OPTIFLEX XTENSE. Full Visual Range EDOF IOL
See the World – Brazil

Travelling the world, admire colors and contrast nuances, at all distances, far, intermediate and near. Without the need of reading glasses.
Enjoy colors and contrast at any distance without disturbing glare or halos*

OPTIFLEX XTENSE Comfort Plus represents a major revolution in cataract outcomes and presbyopia correction. A hydrophobic EDOF intraocular lens with purely refractive optic, OPTIFLEX XTENSE delivers a continuous full visual range, from distance to intermediate to true near vision. Expanded visual range, minimal compromise and maximum clarity.



* Similar to monofocal IOLs

20/03/2026

𝐀𝐈𝐎𝐂 𝟐𝟎𝟐𝟔 𝐢𝐧 𝐉𝐚𝐢𝐩𝐮𝐫 has been a fantastic congress for us for many great reasons. We are particularly proud to 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥𝐥𝐲 𝐥𝐚𝐮𝐧𝐜𝐡 𝐢𝐧 𝐈𝐧𝐝𝐢𝐚, one of our most expected innovations: 𝐎𝐩𝐭𝐢𝐟𝐥𝐞𝐱 𝐗𝐓𝐄𝐍𝐒𝐄 𝐂𝐨𝐦𝐟𝐨𝐫𝐭 𝐏𝐥𝐮𝐬, 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐯𝐢𝐬𝐢𝐨𝐧 𝐫𝐚𝐧𝐠𝐞 𝐄𝐃𝐎𝐅 𝐈𝐎𝐋 𝐭𝐡𝐚𝐭 𝐜𝐨𝐫𝐫𝐞𝐜𝐭𝐬 𝐩𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚. We were honoured during the launch by the precious presence of 𝐃𝐫 𝐒𝐫𝐢 𝐆𝐚𝐧𝐞𝐬𝐡, 𝐃𝐫 𝐃. 𝐑𝐚𝐦𝐚𝐦𝐮𝐫𝐭𝐡𝐲, 𝐃𝐫 𝐊. 𝐏. 𝐊𝐮𝐝𝐥𝐮, 𝐃𝐫 𝐒𝐮𝐡𝐚𝐬 𝐇𝐚𝐥𝐝𝐢𝐩𝐮𝐫𝐤𝐚𝐫 𝐚𝐧𝐝 𝐃𝐫 𝐓𝐚𝐧𝐯𝐢 𝐇𝐚𝐥𝐝𝐢𝐩𝐮𝐥𝐤𝐚𝐫. Interest shown in Optiflex XTENSE has completely fulfilled our expectations.

A special thank you to all doctors who have participated in our events and activities, our hands-on training program on loading and implantation of 𝐄𝐘𝐄𝐂𝐑𝐘𝐋 𝐏𝐡𝐚𝐤𝐢𝐜 𝐈𝐎𝐋 𝐚𝐭 𝐨𝐮𝐫 𝐨𝐧-𝐛𝐨𝐨𝐭𝐡 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐋𝐚𝐛, 𝐭𝐡𝐞 𝐂𝐨𝐟𝐟𝐞𝐞 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 𝐄𝐱𝐩𝐞𝐫𝐭𝐬 𝐒𝐞𝐬𝐬𝐢𝐨𝐧𝐬, 𝐋𝐢𝐯𝐞 𝐈𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰𝐬 𝐚𝐧𝐝 𝐨𝐮𝐫 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 𝐨𝐧 𝐩𝐫𝐞𝐦𝐢𝐮𝐦 𝐈𝐎𝐋𝐬.

Thank you to all members of the Biotech team for once again doing such a great job.

11/03/2026

Comparative Study Demonstrates EYECRYL™ SERT Superior Intermediate Outcomes vs TECNIS Eyhance

A prospective comparative clinical study evaluating Eyecryl SERT and TECNIS Eyhance has been published (Cureus, January 2026), demonstrating Key 6-Month Findings:

1. Superior binocular and monocular intermediate visual acuity (66 cm), statistically significant (p < 0.0001)
2. Superior contrast sensitivity across all tested spatial frequencies
3. Higher reading speeds at both near and intermediate distances
4. Significant advantage at intermediate defocus levels
5. No adverse events or PCO observed during follow-up

Results do not only demonstrate strong intermediate acuity at the standardized 66 cm testing distance, but a broader intermediate functional benefit in defocus analysis — supporting modern task-oriented vision. For surgeons seeking evidence-based differentiation in the EDOF category,
these findings definitely provide clinically relevant comparative data.
As patient expectations increasingly center around functional intermediate performance, published head-to-head outcomes become critical in lens selection strategy.
(Source: Comparative clinical study, Cureus 2026)

Read the whole study in the following link
https://biotechhealthcare.com/wp-content/uploads/2026/01/Eyecryl-Sert-Publication.pdf

09/03/2026

World Glaucoma Week is a global initiative organized by the World Glaucoma Association to raise awareness about glaucoma.
Glaucoma is one of the leading causes of preventable blindness.

At the current time (2025) there are about 80 million people worldwide with glaucoma. By the year 2040, it is estimated that 22 million individuals worldwide will be blind from glaucoma.
Most people with glaucoma are not aware of it: most glaucoma patients have zero symptoms.

The goal is to alert everyone to have regular eye and optic nerve checks to detect glaucoma as early as possible because there are available treatments for all forms of glaucoma to prevent visual loss.
Early diagnosis is key to slow down the irreversible damage caused by glaucoma. Catch the disease early and you have a great chance of preserving your vision for the years to come.

Make sure to have an eye exam regularly!

08/03/2026

International Women’s Day (IWD), celebrated annually on March 8th, honors the achievements of women across all aspects of life - social, economic, cultural, and political - while also advocating for gender equality.

International Women’s Day is a day to also remember that there is still a long way to go in terms of gender equality & inclusion. At Biotech Healthcare we support the empowering of women, as part of our vision.


A quick glimpse at our programmed activities during AIOS Conference at the JECC: - Product Launch- EYECRYL Phakic Experi...
05/03/2026

A quick glimpse at our programmed activities during AIOS Conference at the JECC:

- Product Launch
- EYECRYL Phakic Experience Lab
- Coffee with Experts Sessions
- Satellite Symposium

All details of our extensive program soon in our local social medial.
Stay tuned!

Don’t miss them out! Looking forward to seeing you all at the AIOC 2026!

at Jaipur’s JECC.
Visit us at our stand, BOOTH A106.

Adresse

Obergrundstrasse 17, 6002 Luzern
Lucerne
6003

Öffnungszeiten

Montag 09:00 - 17:30
Dienstag 09:00 - 17:30
Mittwoch 09:00 - 17:30
Donnerstag 09:00 - 17:30
Freitag 09:00 - 17:30
Samstag 09:00 - 17:30

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Biotech Healthcare erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Biotech Healthcare senden:

Verknüpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Kategorie

Our Story

Biotech Healthcare Group, founded in 1999, manufactures and supplies a range of products in Ophthalmology, Dermatology, Orthopaedics & Urology verticals. We are one of the leading manufacturers and suppliers of intraocular lenses, ophthalmic solutions and diagnostic range of equipment for eye care industry with production capacity of over 2.4 million lenses per year.

With our sales and marketing Headquarters in Luzern, Switzerland, we have established research & development centers with state-of-the-art manufacturing facilities in Roscommon, Ireland and Ahmedabad, India. Today, our products reach in more than 90 countries including Europe, South America, Middle East, South-East Asia and SAARC Nations.

Our people at Biotech come from divergent backgrounds and experiences. Our common goal, urge for innovation, passion for developing high quality products & commitment towards customer service helps us to move every step closer towards serving people for a better life.